-
Symbol
-
IPA
-
Investment type
-
Equity / Common Shares, no par value
-
Latest Disclosed Shares Owned
-
1,828,365 shares
-
Security Ownership %
-
5.8%
Charmquark TWEE ownership in ImmunoPrecise Antibodies Ltd. Common Shares, no par value (IPA)
24 Jan 2025 - Charmquark TWEE has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,828,365 shares of ImmunoPrecise Antibodies Ltd. Common Shares, no par value (IPA).
This represents 5.8% ownership of the company.
This is the first filing by Charmquark TWEE disclosing ownership of ImmunoPrecise Antibodies Ltd. Common Shares, no par value (IPA).